FDA Orange Book
Is there a generic for Elliotts B Solution?
Elliotts B Solution contains calcium chloride, dextrose, magnesium sulfate, potassium chloride, sodium bicarbonate, sodium chloride and sodium phosphate dibasic heptahydrate. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Elliotts B Solution (calcium chloride, dextrose, magnesium sulfate, potassium chloride, sodium bicarbonate, sodium chloride and sodium phosphate dibasic heptahydrate).
Run it in Rivvi
Map Elliotts B Solution and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Elliotts B Solution products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| injectable, intrathecal | 0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML | Marketed (Rx) | None | 0 | None |
NDA 020577, held by LUKARE MEDICAL LLC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Elliotts B Solution NDC codes
Questions
Is there a generic for Elliotts B Solution?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Elliotts B Solution (calcium chloride, dextrose, magnesium sulfate, potassium chloride, sodium bicarbonate, sodium chloride and sodium phosphate dibasic heptahydrate).
What is the generic name for Elliotts B Solution?
The active ingredient in Elliotts B Solution is calcium chloride, dextrose, magnesium sulfate, potassium chloride, sodium bicarbonate, sodium chloride and sodium phosphate dibasic heptahydrate, per the FDA Orange Book.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.